J A Kemp Pushing the Boundaries of Patent Scope in Europe With Antibodies and SPCs

Patent maximalism is still a serious and an urgent issue for the EPO to tackle; the Office seems to have been dedicated to the interests of litigation firms rather than science and technology sectors

techrights.org